Reporting owner · CIK 0002010224

Lantheus Alpha Therapy, LLC

Visual SEC Form 4 history across 1 companies, 3 transactions and 2 filings.

10%Perspective Therapeutics, Inc.
Open-market mix
Filings2Form 4 records
Buying$00 purchases
Selling$488.4K3 sales
Net value−$488.4KBuys minus sells
Companies11 securities
Most recentSep 02, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Aug 262Sep 26

Net value flow

Buys minus sells

Aug 26
−$245.6K
Sep 26
−$242.8K

Transaction texture

Ownership and ticket size

Average P/S size$162.8K
Median P/S size$131.2K
Direct3
Indirect0
Sep 02, 2026sale

Filing-only signals

Deterministic matches in this insider's history

No filing-only signal badges matched this history.

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Perspective Therapeutics, Inc. on Sep 02, 2026 valued at $131,219.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Perspective Therapeutics, Inc. on Sep 02, 2026 valued at $131,219.

Review SEC filing

Associated companies

Visual map of known reporting history

Lantheus Alpha Therapy, LLC Insider Activity FAQ

SEC Form 4 context

Who is Lantheus Alpha Therapy, LLC?

Lantheus Alpha Therapy, LLC is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002010224.

Which companies has Lantheus Alpha Therapy, LLC reported transactions for?

Perspective Therapeutics, Inc.

When was Lantheus Alpha Therapy, LLC's latest insider buy?

No open-market insider purchase is available for this period.

When was Lantheus Alpha Therapy, LLC's latest insider sale?

sale at Perspective Therapeutics, Inc. on Sep 02, 2026 valued at $131,219.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.